Present state and future development of the therapy of Alzheimer disease.
Pomponi
M
M
Department of Chemistry and P. Biochemistry, Università Cattolica del Sacro Cuore, Roma, Italy.
Giacobini
E
E
Brufani
M
M
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000209:etiology; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000818:Animals; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006801:Humans; D009414:Nerve Growth Factors / Q000627:therapeutic use; D009479:Neuropeptides / Q000627:therapeutic use; D010277:Parasympathomimetics / Q000627:therapeutic use; D010830:Physostigmine / Q000627:therapeutic use
D016229:Amyloid beta-Peptides; D002800:Cholinesterase Inhibitors; D009414:Nerve Growth Factors; D009479:Neuropeptides; D010277:Parasympathomimetics; D010830:Physostigmine